🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or prison.

Service Response and Material Elimination

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with photos of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

Within minutes of joining one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Within these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.